Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib sodium + esketamine + incision infiltration for postoperative analgesia and delirium after spinal surgery
ChiCTR2400090230Phase 4Completed
- Sponsor
- Tai'an City Central Hospital
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of parecoxib, esketamine, sufentanil and ropivacaine in postoperative pain and postoperative delirium (POD) (2 arms), sponsored by Tai'an City Central Hospital. Primary endpoint: Postoperative pain score. Started Sep 2024; status: completed.
02
Drugs
parecoxibesketaminesufentanilropivacaine
03
Conditions
postoperative painpostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400090230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090230.